Quest Diagnostics
885 hedge funds and large institutions have $15B invested in Quest Diagnostics in 2024 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 312 increasing their positions, 294 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
885
Holders Change
+47
Holders Change %
+5.61%
% of All Funds
11.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
122
Increased
312
Reduced
294
Closed
59
Calls
$63.1M
Puts
$35M
Net Calls
+$28.2M
Net Calls Change
+$22.3M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$247M |
| 2 |
JPMorgan Chase & Co
New York
|
+$138M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$88.8M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$75.1M |
| 5 |
Millennium Management
New York
|
+$74.1M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$116M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$115M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$82.9M |
| 4 |
Goldman Sachs
New York
|
-$63M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$42.8M |
